Crossmark

Last secrets of ergot and its ingredients are revealed

Crossref DOI link: https://doi.org/10.1007/978-3-662-69811-2_10

Published Online: 2025-04-05

Published Print: 2025

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Petersen, Frank
Funding

Funding for this research was provided by:

Syngenta International

Novartis

Emilia-Guggenheim-Schnurr-Stiftung
License Information

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-01-01
More Information

Chapter History

First Online: 5 April 2025